280 related articles for article (PubMed ID: 28361333)
1. In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine?
Roszkiewicz J; Smolewska E
Curr Rheumatol Rep; 2017 Apr; 19(4):19. PubMed ID: 28361333
[TBL] [Abstract][Full Text] [Related]
2. Prediction of methotrexate efficacy and adverse events in patients with juvenile idiopathic arthritis: a systematic literature review.
van Dijkhuizen EH; Wulffraat NM
Pediatr Rheumatol Online J; 2014; 12():51. PubMed ID: 25525416
[TBL] [Abstract][Full Text] [Related]
3. Prediction of methotrexate intolerance in juvenile idiopathic arthritis: a prospective, observational cohort study.
van Dijkhuizen EH; Bulatović Ćalasan M; Pluijm SM; de Rotte MC; Vastert SJ; Kamphuis S; de Jonge R; Wulffraat NM
Pediatr Rheumatol Online J; 2015; 13():5. PubMed ID: 25745368
[TBL] [Abstract][Full Text] [Related]
4. Cytokine Biomarkers of Disease Activity and Therapeutic Response after Initiating Methotrexate Therapy in Patients with Juvenile Idiopathic Arthritis.
Funk RS; Chan MA; Becker ML
Pharmacotherapy; 2017 Jun; 37(6):700-711. PubMed ID: 28475276
[TBL] [Abstract][Full Text] [Related]
5. The use of methotrexate in children with rheumatic diseases.
Gutiérrez-Suárez R; Burgos-Vargas R
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S122-7. PubMed ID: 21044445
[TBL] [Abstract][Full Text] [Related]
6. ABCB1 and ABCC3 gene polymorphisms are associated with first-year response to methotrexate in juvenile idiopathic arthritis.
de Rotte MC; Bulatovic M; Heijstek MW; Jansen G; Heil SG; van Schaik RH; Wulffraat NM; de Jonge R
J Rheumatol; 2012 Oct; 39(10):2032-40. PubMed ID: 22859359
[TBL] [Abstract][Full Text] [Related]
7. Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis.
Hinks A; Moncrieffe H; Martin P; Ursu S; Lal S; Kassoumeri L; Weiler T; Glass DN; Thompson SD; Wedderburn LR; Thomson W
Ann Rheum Dis; 2011 Aug; 70(8):1395-400. PubMed ID: 21515602
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate in juvenile idiopathic arthritis: towards tailor-made treatment.
Ćalasan MB; Wulffraat NM
Expert Rev Clin Immunol; 2014 Jul; 10(7):843-54. PubMed ID: 24857620
[TBL] [Abstract][Full Text] [Related]
9. A prediction rule for lack of achievement of inactive disease with methotrexate as the sole disease-modifying antirheumatic therapy in juvenile idiopathic arthritis.
Bava C; Mongelli F; Pistorio A; Bertamino M; Bracciolini G; Dalprà S; Davì S; Lanni S; Muratore V; Pederzoli S; Rosina S; Schiappapietra B; Suffia C; Varnier G; Verazza S; Giancane G; Consolaro A; Ravelli A
Pediatr Rheumatol Online J; 2019 Jul; 17(1):50. PubMed ID: 31345226
[TBL] [Abstract][Full Text] [Related]
10. Relationship Between Polymorphisms in Methotrexate Pathway Genes and Outcome of Methotrexate Treatment in a Cohort of 119 Patients with Juvenile Idiopathic Arthritis.
Zajc Avramovič M; Dolžan V; Toplak N; Accetto M; Lusa L; Avčin T
J Rheumatol; 2017 Aug; 44(8):1216-1223. PubMed ID: 28572465
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphisms associated with methotrexate-induced nausea in juvenile idiopathic arthritis.
Kyvsgaard N; Mikkelsen TS; Als TD; Christensen AE; Corydon TJ; Herlin T
Pediatr Rheumatol Online J; 2021 Apr; 19(1):51. PubMed ID: 33794950
[TBL] [Abstract][Full Text] [Related]
12. Use of methotrexate in juvenile idiopathic arthritis.
Ramanan AV; Whitworth P; Baildam EM
Arch Dis Child; 2003 Mar; 88(3):197-200. PubMed ID: 12598376
[TBL] [Abstract][Full Text] [Related]
13. [Methotrexate in the therapy of juvenile idiopathic arthritis].
Holzinger D; Frosch M; Föll D
Z Rheumatol; 2010 Aug; 69(6):496-504. PubMed ID: 20632181
[TBL] [Abstract][Full Text] [Related]
14. S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic Arthritis.
Gohar F; Anink J; Moncrieffe H; Van Suijlekom-Smit LWA; Prince FHM; van Rossum MAJ; Dolman KM; Hoppenreijs EPAH; Ten Cate R; Ursu S; Wedderburn LR; Horneff G; Frosch M; Foell D; Holzinger D
J Rheumatol; 2018 Apr; 45(4):547-554. PubMed ID: 29335345
[TBL] [Abstract][Full Text] [Related]
15.
Roszkiewicz J; Michałek D; Ryk A; Swacha Z; Szmyd B; Smolewska E
Scand J Rheumatol; 2021 May; 50(3):213-217. PubMed ID: 33025831
[No Abstract] [Full Text] [Related]
16. Methotrexate pharmacogenetics in rheumatoid arthritis.
Brinker RR; Ranganathan P
Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S33-9. PubMed ID: 21044431
[TBL] [Abstract][Full Text] [Related]
17. Juvenile idiopathic arthritis: updated guide to administering methotrexate.
Livermore P
Nurs Child Young People; 2014 Feb; 26(1):26-9. PubMed ID: 24517621
[TBL] [Abstract][Full Text] [Related]
18. Associations between gene polymorphisms and treatment outcomes of methotrexate in patients with juvenile idiopathic arthritis.
Chen Y; Zou K; Sun J; Yang Y; Liu G
Pharmacogenomics; 2018 Apr; 19(6):529-538. PubMed ID: 29589488
[TBL] [Abstract][Full Text] [Related]
19. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis.
Batu ED; Sönmez HE; Gülhan B; Arıcı ZS; Topaloğlu R; Bilginer Y
Turk J Pediatr; 2017; 59(1):6-12. PubMed ID: 29168357
[TBL] [Abstract][Full Text] [Related]
20. Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis.
Yanagimachi M; Naruto T; Hara T; Kikuchi M; Hara R; Miyamae T; Imagawa T; Mori M; Kaneko T; Morita S; Goto H; Yokota S
Br J Clin Pharmacol; 2011 Feb; 71(2):237-43. PubMed ID: 21219404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]